The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Adherence challenges with pre-exposure prophylaxis (PrEP) could be overcome if experimental long-acting HIV drug is found to be effective and acceptable.
This World AIDS Day we've chosen ten pivotal events from the history of the HIV epidemic you should know about.
As we mark the 29th World AIDS Day, Sarah Hand says that with enough commitment, political will and funding we have the tools to achieve UNAIDS’ ambitious fast track targets – but only if we recognise the need for a new approach to HIV prevention.
New HIV vaccine trial builds on success of 2009 Thai trial that showed 31.2% effectiveness in preventing HIV.
According to a recent report, 12 million people inject drugs globally, but they are often simply judged, looked down on, condemned or ignored. This has serious health and social consequences for them, their families and their communities – not least in terms of their risk of acquiring or passing on HIV and hepatitis C.
Treatment access gains are to be applauded – but we will get nowhere if we don’t prevent more new infections and reach out to key affected populations.
A new pill technology has the potential to simplify HIV treatment and curb the rise of drug-resistant HIV.
Drug policy based on prohibition hasn't worked. It's time to build on the success of partial-decriminalisation models with an emphasis on health and human rights, says new report.
People who inject drugs are increasingly left behind in the HIV response, with limited access to harm reduction services that secure their rights and their health.
Over 300,000 AIDS-related deaths each year could be prevented through better diagnosis and treatment of fungal infections